Phenotypical characterization of CCR6+ CD4 and CD8 splenocytes in UI and HIV-infected individuals
| . | CCR7 . | CD27 . | CD28 . | CD95 . |
|---|---|---|---|---|
| CD4+CCR6+T cells | ||||
| UI | 32 ± 5.7 | 89.3 ± 2 | 95.8 ± 2.9 | 67.3 ± 5.5 |
| HIV | 30 ± 8.5 | 93.3 ± 2.7 | 92.7 ± 6.3 | 94 ± 1.5* |
| CD8+CCR6+T cells | ||||
| UI | 23.8 ± 5.3 | 74.8 ± 4.9 | 84 ± 4 | 48.5 ± 10.2 |
| HIV | 17.3 ± 3.9 | 85.3 ± 5.5 | 89 ± 3.2 | 88.7 ± 4.8* |
| . | CCR7 . | CD27 . | CD28 . | CD95 . |
|---|---|---|---|---|
| CD4+CCR6+T cells | ||||
| UI | 32 ± 5.7 | 89.3 ± 2 | 95.8 ± 2.9 | 67.3 ± 5.5 |
| HIV | 30 ± 8.5 | 93.3 ± 2.7 | 92.7 ± 6.3 | 94 ± 1.5* |
| CD8+CCR6+T cells | ||||
| UI | 23.8 ± 5.3 | 74.8 ± 4.9 | 84 ± 4 | 48.5 ± 10.2 |
| HIV | 17.3 ± 3.9 | 85.3 ± 5.5 | 89 ± 3.2 | 88.7 ± 4.8* |
Proportion of CCR6+ CD4+ or CD8+ T cells expressing differentiation markers CCR7, CD27, CD28, or CD95, reported as percentage ± SEM. Four frozen splenocytes suspensions from HIV-infected patients and 4 from UI individuals were sampled.
*P < .05.